Dec 23, 2025 · A 2025 oncology year in review covering AI in cancer care, FDA drug approvals, immunotherapy, liquid biopsy screening, mRNA vaccines, and global cancer equity.

5 days ago · From KRAS inhibitors in metastatic CRC to radioligands and PET imaging agents in prostate cancer, dozens of oncologic approvals were reported in 2025. Given the robust year …

1 day ago · December 2025 saw pivotal FDA approvals, including the first CAR T-cell therapy for marginal zone lymphoma and a novel blood-based assay for prostate cancer biopsy risk …

Jul 1, 2025 · In the second quarter of 2025, FDA issued 13 new oncology approvals, including treatments for rare cancers, head and neck cancer, and more.

Jun 18, 2025 · In the first half of 2025, the FDA approved 7 novel drugs for oncologic conditions, including for non-small cell lung cancer; ovarian cancer; and metastatic, hormone receptor …

3 days ago · Novel Drug Approvals for 2025 What are "Novel" Drugs? "Novel" drugs are new drugs never before approved or marketed in the U.S.

May 28, 2025 · In 2025, MD Anderson clinicians and researchers will present more than 120 studies. Five stand out for their potential to change the way cancers are treated. They include …

In July of 2025, the U.S. Food and Drug Administration approved various anti-cancer treatments and therapeutic approaches across a range of disease types, such as multiple myeloma, non …

Dec 22, 2025 · 2025 has seen 43 novel FDA drug approvals – new drugs never before approved or marketed in the U.S – introducing high-impact therapies that are redefining what …

Jun 18, 2025 · Stay informed on the latest FDA oncology drug approvals in 2025! Explore breakthrough cancer treatments, understand approval pathways, and discover the impact on …